Healthcare with Confidence
Leading Oncologist – Melanoma and Skin Cancer
Position: Chairman of the Ella Lamelbaum Institute for Melanoma and Immunooncology Deputy Director of Oncology Department
Hospital: Sheba Academic Medical Center
Prof. Schachter is in the Forbes list of the best Israeli doctors
Qualified Medical Consultation Online, Second Opinion
Qualified Medical Consultation
Early and Metastatic stages of: Melanoma and Skin Cancer
- Immunotherapy intravenous and intrathecal
- Targeted therapy
- Adjuvant therapy
- Radiation therapy
- TIL therapy for melanoma
Send Your Medical Files Book Consultation Now
Prof. Jacob Schachter is one of Israel’s leading experts in melanoma and immuno-oncology. He serves as:
- Head of the Israeli Melanoma Society Forum
- Member of the Israeli Society of Oncology and Clinical Radiotherapy
- Head of the Department of Oncology at the Faculty of Medicine, Tel Aviv University
Throughout his career, Prof. Schachter has led numerous epidemiological studies, with his research published in top-tier international medical journals.
Leadership in Advanced Melanoma Treatment
Under Prof. Schachter’s leadership, the Ella Lemelbaum Institute for Melanoma and Immuno-Oncology at Sheba Medical Center offers a unique and comprehensive approach to the treatment of melanoma.
The institute focuses on:
- Personalized treatment plans based on the latest research
- Monitoring of high-risk patients in partnership with the Advanced Technologies Center
- Advanced surgical techniques, in collaboration with the Departments of Plastic Surgery and Surgical Oncology
- Innovative therapies for early and advanced stages of melanoma
A Global Center for Experimental Melanoma Therapies
The institute is also conducting some of the world’s most advanced experimental treatments for melanoma, including novel immunotherapies like TIL therapy.
There are only two centers worldwide offering this level of experimental treatment:
- The National Institutes of Health (NIH) in the United States
- Chaim Sheba Medical Center in Tel Hashomer, Israel
